Chloroprocaine Hydrochloride Patent Expiration

1. Clorotekal patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8969412 B BRAUN MEDICAL INC Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture
Sep, 2026

(2 years from now)

US9504666 B BRAUN MEDICAL INC Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Dec, 2033

(9 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 26, 2020

Market Authorisation Date: 26 September, 2017

Treatment: A method for inducing a regional anaesthesia via intrathecal administration of a patented preservative free solution for injection (with a specific composition, ph, osmolality and density) containing ...

Dosage: SOLUTION

More Information on Dosage

CLOROTEKAL family patents

Family Patents

2. Iheezo patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792271 HARROW EYE Topical formulations of chloroprocaine and methods of using same
Sep, 2038

(14 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 27, 2025

Market Authorisation Date: 27 September, 2022

Treatment: Method of inducing ocular anesthesia

Dosage: GEL

More Information on Dosage

IHEEZO family patents

Family Patents